Open Access

End-tidal carbon dioxide monitoring may be associated with a higher possibility of return of spontaneous circulation during out-of-hospital cardiac arrest: a population-based study

  • Jiun-Jia Chen1, 2,
  • Yi-Kung Lee1, 2,
  • Sheng-Wen Hou3,
  • Ming-Yuan Huang4,
  • Chen-Yang Hsu5 and
  • Yung-Cheng Su1, 2Email author
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine201523:104

https://doi.org/10.1186/s13049-015-0187-y

Received: 19 February 2015

Accepted: 15 November 2015

Published: 24 November 2015

Abstract

Background

During cardiac arrest, end-tidal carbon dioxide (ETCO2) monitoring is recommended as a chest compression performance indicator. However, its frequency of use during out-of-hospital cardiac arrest (OHCA) and its benefits have never been evaluated in real clinical situations.

Objective

We investigated OHCA patients in Taiwan to evaluate the frequency of ETCO2 monitoring and its effects on sustained return of spontaneous circulation (ROSC).

Methods

We sampled the Taiwan National Health Insurance claims database, which contains 1 million beneficiaries. All adult beneficiaries older than 18 years who presented with OHCA and received chest compression between 1 January 2005 and 31 December 2012 were enrolled. We further identified patients with ETCO2 monitoring and matched each 1 with 20 patients who did not receive ETCO2 monitoring based on their propensity scores. A simple conditional logistic regression model was applied to compare the odds ratio (OR) for sustained ROSC in the matched cohorts.

Results

A total of 5041 OHCA patients were enrolled. The frequency of ETCO2 monitoring has increased since 2010 but still is low. After matching, 53 patients with ETCO2 monitoring and 1060 without ETCO2 monitoring were selected. The OR of sustained ROSC in the ETCO2 group was significantly increased (2.38, 95 % CI 1.28–4.42).

Conclusion

Patients who received ETCO2 monitoring during OHCA had a higher possibility of sustained ROSC, but the overall use of ETCO2 monitoring is still low despite strong recommendations for its use.

Keywords

End-tidal carbon dioxide Cardiac arrest Out-of-hospital cardiac events Capnography

Introduction

Out-of-hospital cardiac arrest (OHCA) is a major cause of morbidity and mortality around the world. In the United States, the estimated annual incidence of OHCA ranges from 300,000 to 350,000 each year [1, 2]. Wider application of the improved algorithms in the Advanced Cardiac Life Support (ACLS) recommendations, such as early defibrillation and high-quality cardiopulmonary resuscitation (CPR), have led to increased survival rates among OHCA patients [35]. Because CPR consistency is an important factor, end-tidal carbon dioxide (ETCO2) monitoring has recently been suggested as an adjunctive tool for monitoring the effectiveness of chest compressions during resuscitations [3, 6].

The height of the ETCO2 level during CPR is well correlated with cardiac output during chest compression [79], and feedback about an inadequate level can help the team to evaluate possible causes such as misplaced or displaced tracheal tube, fatigue of the team member, suboptimal chest compressions, cardiac tamponade, or pneumothorax. In this way the resuscitation can be individualized, and better CPR delivery may be achieved. However, to our knowledge, despite the strong recommendations from ACLS, the frequency of ETCO2 use during OHCA and its possible influence on CPR quality and survival, have not been evaluated in population-based studies.

In this study, a large administrative database was used to assess sustained ROSC in OHCA patients who were treated with ETCO2 monitoring in Taiwan. We hypothesized that use of ETCO2 monitoring may be associated with a higher possibility of sustained ROSC because of real-time feedback about the quality of chest compression. The results of this study may help clinicians to place more emphasis on the use of ETCO2 monitoring in frequently encountered situations.

Methods

Ethics statement

This study was initiated after its protocol was approved by the Institutional Review Board of Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taiwan, and was conducted in conformity with the Declaration of Helsinki.

Database

The National Health Insurance (NHI) program was implemented in Taiwan in 1995 and provides compulsory universal health insurance. It enrolls about 99 % of the Taiwanese population and contracts with 97 % of all the country’s medical providers [10, 11]. The database contains comprehensive information about all insured subjects, including sex, date of birth, residential or work area, dates of clinical visits, diagnoses identified by International Classification of Diseases (Ninth Revision) Clinical Modification (ICD-9-CM) diagnostic codes, details of prescribed medications and procedures administered, expenditure amounts, and outcome at hospital discharge (i.e., recovered, died, or transferred out) [12]. A random sample of 1,000,000 people who received health benefits from the NHI program was selected based on calendar-year 2005 reimbursement data and was considered representative of the entire population; according to the Taiwan National Health Research Institute, the group did not differ statistically from the larger cohort in age, sex, or health care costs [13, 14]. This sample was used as our study cohort.

Study population

The population sample was followed from 1 January 2003 to 31 December 2012 (a total of 10 years). For our study cohort, we first identified individuals who were still alive in 2005 and were older than 18 years at the time of OHCA. OHCA was defined by the ICD-9-CM codes ventricular fibrillation (427.4), cardiac arrest (427.5), and sudden death (798.0–798.9) in outpatient clinic records. To avoid including patients who had Do Not Attempt Resuscitation orders, no chance of survival, and coding errors, we excluded patients on whom no chest compression was attempted. ETCO2 monitoring was defined by the charge record for continuous capnography during the visits. For each charge record of ETCO2, the institutes could claim for about US$ 14 from the Bureau of National Health Insurance. After exclusions, we identified 83 patients who received ETCO2 monitoring and 4958 who did not receive such monitoring. In order to identify sustained ROSC, each patient was tracked if he or she was hospitalized after OHCA (Fig. 1).
Fig. 1

Flow diagram of the population-based study

Prespecified covariates

In order to investigate a significant influence on survival associated with ETCO2-monitoring, we included several covariates in the analysis; age, sex, calendar year, urbanization level (i.e., urban, suburban, and rural), health care institutes, and socioeconomic status (SES). Income-related insurance payment amounts were used as a proxy measure of individual SES at follow-up. People were divided into 3 groups: (1) low SES: payment lower than US$571 per month (New Taiwan Dollars [NT$] 20,000); (2) moderate SES: payment between US$571 and US$1141 per month (NT$ 20,000–40,000); and (3) high SES: payment of US$1142 or more per month (NT$40,001 or more) [12]. The health care institutes visited by patients were classified into 4 levels (medical centers, regional hospitals, local hospitals, and clinics) based on hospital accreditation. Two additional covariates that may be related to sustained ROSC following resuscitation, the CPR duration and attempted defibrillation, were identified based on charge records. Finally, the prevalence of selected comorbid conditions (i.e., diabetes, hypertension, coronary artery disease, hyperlipidemia, malignancies, heart failure, atrial fibrillation, intracranial hemorrhage, ischemic stroke, chronic renal insufficiency, and liver cirrhosis) and the Charlson Comorbidity Index (CCI) score were determined using discharge diagnoses either during outpatient clinic visits or hospitalizations before 1 January 2005. The CCI is a scoring system that assigns weights to important concomitant diseases; it has been validated for use in studies that employ ICD-9-CM data [14, 15].

Propensity score methods

In this study, the propensity score was the conditional probability for using ETCO2 monitoring in the presence of possible confounders. The prespecified covariates were added into a multivariable logistic regression model to predict the probability of ETCO2 use. The predicted probability from the model was used as the propensity score for each patient. We then matched each patient in the ETCO2 group to 20 patients in the untreated group with the closest propensity score using a standard greedy-matching algorithm [16] and compared the probability of survival benefits between these groups.

Statistical analysis

The SAS statistical package, version 9.4 (SAS Institute, Inc., Cary, NC, USA) was used for data analysis. All covariates were taken as categorical variables except age, calendar year, CPR duration, and propensity score, which were treated as continuous variables. Categorical variables were compared using Pearson’s chi-square test, and continuous variables were assessed using the t test to determine baseline heterogeneity in the 2 groups. Simple conditional logistic regression models were then used to calculate the ORs of sustained ROSC and survival to hospital discharge for patients with ETCO2 use in the matched group.

In order to further assess the robustness of our results, we sampled another cohort by matching each patient in the ETCO2 group to 4 patients in the untreated group using the same method (Fig. 1). We compared the crude ORs and risk differences of survival benefits among 2 matched cohorts and the original group to evaluate if the results are similar. We also evaluated the extent of the effect of a potentially unmeasured confounder in accounting for the results [17]. A two-tailed P value of 0.05 was considered significant.

Results

The distribution of demographic characteristics and selected morbidities in both groups is shown in Table 1. There were 6909 episodes of OHCA during the 8-year period. The population incidence of OHCA in Taiwan was 86.3 per 100,000 person-years. After exclusion, there were 83 patients in the ETCO2 group and 4958 in the untreated group. The overall baseline characteristics are similar between the 2 groups, except the patients monitored with ETCO2 were more likely to have liver cirrhosis. In addition, patients who visited medical centers also had a higher probability of receiving ETCO2 monitoring. The proportion of ETCO2 use gradually increased after 2010 but still was low. In 2012, only 5.8 % of OHCA patients received ETCO2 monitoring (Table 2). Detailed information about the frequency of ETCO2 use are summerized in the Additional file 1. After resuscitation, 658 patients (13 %) had records of sustained ROSC, including 25 patients in the ETCO2 group and 633 in the untreated group. Among them, 1 patient (4 %) in the ETCO2 group and 96 (15.2 %) in the untreated group had a record of survival to hospital discharge, respectively. The crude odds ratio (OR) of sustained ROSC for the ETCO2 group was 2.95 (95 % CI 1.83–4.74).
Table 1

Baseline characteristics of the ETCO2 group and the untreated group

Variables

ETCO2 group

Untreated group

P value

(n = 83)

(n = 4958)

Male, no. (%)

44

53.0

3138

63.3

0.054

Mean age in years (SD)

71.3

15.2

67.9

17.6

0.088

Attempted defibrillation, no. (%)

14

16.9

878

17.7

0.842

Mean CPR time (10 min) (SD)

2.4

1.4

2.4

1.6

0.927

Socioeconomic status, no. (%)

    

0.236

 Low

56

67.5

3586

72.3

 

 Moderate

26

31.3

1212

24.5

 

 High

1

1.2

160

3.2

 

Urbanization level, no. (%)

    

0.118

 Urban

26

31.3

1174

23.7

 

 Suburban

29

35.0

2259

45.6

 

 Rural

28

33.7

1525

30.7

 

Diabetes, no. (%)

25

30.1

1255

25.3

0.318

Hypertension, no. (%)

43

51.8

2434

49.1

0.624

Coronary artery disease, no. (%)

16

19.3

1075

21.7

0.598

Hyperlipidemia, no. (%)

21

25.3

893

18.0

0.087

Malignancies, no. (%)

6

7.2

231

4.7

0.273

Heart failure, no. (%)

1

1.2

255

5.1

0.105

Atrial fibrillation, no. (%)

3

3.6

107

2.2

0.368

Charlson comorbidity index score, no. (%)

    

0.821

 0

25

30.1

1631

32.9

 

 1

24

28.9

1307

26.4

 

 ≥ 2

34

41.0

2020

40.7

 

Intracerebral hemorrhage, no. (%)

1

1.2

108

2.2

0.545

Ischemic stoke, no. (%)

16

19.3

887

17.9

0.744

Chronic renal insufficiency, no. (%)

2

2.4

233

4.7

0.326

Liver cirrhosis, no. (%)

16

19.3

550

11.1

0.019

Health care institutes, no. (%)

    

<0.001

 Medical centers

36

43.4

1108

22.3

 

 Regional hospitals

41

49.4

2497

50.4

 

 Local hospitals

6

7.2

1333

26.9

 

 Clinics

0

0

20

0.4

 

Mean propensity score (SD)

0.046

0.041

0.016

0.021

<0.001

Table 2

Frequency of ETCO2 use

 

Frequency of ETCO2 use

Year

ETCO2 use

Untreated group

NO.

%

NO.

%

2005

7

1.32

522

98.68

2006

2

0.35

571

99.65

2007

5

0.86

574

99.14

2008

7

1.04

666

98.96

2009

0

0

643

100

2010

7

1.07

646

98.93

2011

14

2.03

675

97.97

2012

41

5.84

661

94.16

Next, 53 patients in the ETCO2 group and 1060 in the untreated group were selected after propensity score matching algorithm. In the subcohort, 165 patients survived, including 15 in the ETCO2 group and 150 in the untreated group. Among them, 1 patient (6.7 %) in the ETCO2 group and 22 (14.7 %) in the untreated group had a record of survival to hospital discharge, respectively. The basic characteristics of these 2 subgroups are summarized in Table 3. After matching, all baseline characteristics were similar between the 2 groups. A simple conditional logistic regression model was used to estimate the OR for sustained ROSC and remained significantly higher in patients with ETCO2 use (2.38, 95 % CI 1.28–4.42, P = 0.006). A simple conditional logistic regression model was again used to estimate the OR of survival to hospital discharge but failed to find treatment benefit regarding ETCO2 use (OR 0.91, 95 % CI 0.12–6.90 P = 0.924).
Table 3

Baseline characteristics in the propensity-matched cohort

Variables

ETCO2 group

Untreated group

P value

(n = 53)

(n = 1060)

Male, no. (%)

27

50.9

644

60.8

0.154

Mean age in years (SD)

68.9

15.9

69.6

16.7

0.776

Attempted defibrillation, no. (%)

11

20.8

183

17.3

0.513

Mean CPR time (10 min) (SD)

2.7

1.4

2.5

1.6

0.394

Socioeconomic status, no. (%)

    

0.864

 Low

38

71.7

727

68.6

 

 Moderate

14

26.4

316

29.8

 

 High

1

1.9

17

1.6

 

Urbanization level, no. (%)

    

0.929

 Urban

13

24.5

276

26.0

 

 Suburban

23

43.4

469

44.3

 

 Rural

17

32.1

315

29.7

 

Diabetes, no. (%)

11

20.8

272

25.7

0.424

Hypertension, no. (%)

26

49.1

521

49.2

0.989

Coronary artery disease, no. (%)

10

18.9

200

18.9

1.000

Hyperlipidemia, no. (%)

10

18.9

211

19.9

0.853

Malignancies, no. (%)

3

5.7

44

4.2

0.594

Heart failure, no. (%)

1

1.9

19

1.8

0.959

Atrial fibrillation, no. (%)

1

1.9

16

1.5

0.827

Charlson Comorbidity Index score, no. (%)

    

0.935

 0

19

35.9

355

33.5

 

 1

15

28.3

305

28.8

 

 ≥ 2

19

35.9

400

37.7

 

Intracerebral hemorrhage, no. (%)

1

1.9

26

2.5

0.794

Ischemic stoke, no. (%)

8

15.1

198

18.7

0.512

Chronic renal insufficiency, no. (%)

2

3.8

36

3.4

0.883

Liver cirrhosis, no. (%)

4

7.6

128

12.1

0.320

Health care institutes, no. (%)

    

0.959

 Medical centers

15

28.3

288

27.2

 

 Regional hospitals

32

60.4

639

60.3

 

 Local hospitals

6

11.3

133

12.6

 

 Clinics

0.0209

0.0125

0.0207

0.0125

0.917

Crude ORs and risk differences among the original group and two matched cohorts were found to be similar. The results are summarized in Table 4. Sensitivity analyses showed that an unmeasured confounder present in 10 % of the study population would be required to elevate the possibility of sustained ROSC by a factor of 3.2. Among patients with ETCO2 use, the confounder also would have to be approximately 3.2 times more prevalent than that among the untreated group in order to explain a lower 95 % confidence limit HR of 1.28 (Fig. 2).
Table 4

Comparison of ORs and risk differences among the original group and matched cohorts

  

ETCO2 group (n)

Untreated group (n)

ORs (95 % CI)

Risk differences (95 % CI)

Original group

ROSC(+)

25

633

2.95 (1.83–4.74)

0.17 (0.07–0.27)

ROSC(−)

58

4325

1:4 matched cohort

ROSC(+)

25

56

2.12 (1.23–3.68)

0.13 (0.02–0.23)

ROSC(−)

58

276

1:20 matched cohort

ROSC(+)

15

150

2.39 (1.29–4.46)

0.14 (0.02–0.26)

ROSC(−)

38

910

Fig. 2

Sensitivity analyses for an unmeasured confounding factor

Discussion

The ACLS guideline for using ETCO2 monitoring during CPR provides the basis on which providers can have real-time feedback about the quality of chest compressions, thus offering patients a better chance of survival [18, 19]. To our knowledge, ours is the first study regarding possible survival benefits with ETCO2 monitoring in real clinical situations. In this study, we evaluated the sustained ROSC of patients in Taiwan who received ETCO2 monitoring following OHCA. The database corresponded well to the characteristics of the whole population; therefore, loss of follow-up or selection bias were not concerns. Although the overall survival rates of OHCA patients in Asia were found to be low [20], patients with ETCO2 monitoring during resuscitation still had a higher possibility of sustained ROSC (OR 2.38, 95 % CI 1.28–4.42). Although there were relatively few patients in the treatment group, based on our sample size of matched cohort and ORs the statistical power still achieved 1.0.

ETCO2 monitoring by itself cannot directly improve the quality of CPR administered. However, based on the real-time feedback about the patient’s ETCO2 level, the code team can adjust their management to achieve better chest compression quality, which may in turn result in a better outcome. Moreover, ETCO2 monitoring may also serve as a proxy for better team performance because teams or institutes that use ETCO2 monitoring may have better insights about the importance of CPR performance and thus may have better outcomes. Increased CPR quality may increase the probability of the return of spontaneous circulation. However, in the absence of data linking ETCO2 measurements with the quality markers of chest compressions in our study, no causality inference can be drawn currently.

This study is also the first one based on national data about the use of capnography during OHCA. Despite of the strong recommendation for its use, ETCO2 monitoring in OHCA patients is still low in Taiwan. Even in 2012, the overall percentage of ETCO2 monitoring was only 5.84 %. According to the recommendations of the ACLS guidelines and the possible survival benefits found in this study, further emphasis should be placed on the routine use of ETCO2 monitoring during OHCA.

Limitations

First, our findings were generated from administrative data. The definitions of OHCA were based on ICD-9-CM codes, which are useful for insurance reimbursement but may not be exact substitutes for precise operative definitions. There is also lack of data whether ETCO2 monitoring was performed during or after chest compressions. We validated the selection processes by analyzing 150 medical records of patients with OHCA randomly selected from the electronic database from 2010 to 2012 at Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation. All 118 patients who were charged with chest compression had documented CPR records. Among 69 patients with ETCO2 charge records, the confirmation of use was found by documented CO2 levels during resuscitations. All 42 patients with records of hospitalization were alive before admissions. These selection processes yielded positive predictive values of 100 %.

Second, the percentage of ETCO2 monitoring in our study cohort was only 1.6 %, which may be an underestimate of the true number of patients who actually were monitored. In clinical practice in Taiwan, procedures are charged either by healthcare or administrative staff. In a busy situation such as resuscitation, staff may forget to charge for the ETCO2 monitoring in some patients. Although the extent of crossover to the treatment category cannot be assessed in this study, according to the intention-to-treat analytical principle, the result in this study would show only a bias toward a null result, and the estimation of OR would be more conservative than the actual number reported.

Third, the overall percentage of sustained ROSC (13 %) is low compared with results reported in other publications [20, 21]. Results similar to ours were found in a study published by Huang et al. [22], and fewer shockable rhythms in that study may account for the similarity. Because of the limited number of cases, we failed to find benefits of ETCO2 monitoring on patients’ survival to hospital discharge. Further study should be conducted to evaluate if chest compression monitoring by ETCO2 can improve survival to hospital discharge and, perhaps, if it can be associated with better cerebral performance.

Fourth, for an observational study, confounding by indication may be a concern even after one applies propensity score matching to establish the comparability between groups that use ETCO2 monitoring or do not. For example, in patients with a lower likelihood of survival, physicians may be less likely to use ETCO2 monitoring during resuscitation. However, because the outcome of survival is not perfectly predictable beforehand, such an argument is not plausible. Moreover, because the baseline characteristics were similar between the ETCO2 group and the untreated group even before matching, we believe that resuscitation teams would use ETCO2 monitoring guidelines instead of clinical judgments.

Fifth, with the use of propensity score analyses to adjust for possible confounding, we also lost the ability to evaluate other possible covariates of survival. Finally, although we extensively adjusted for many possible covariates, unmeasured confounding and the possibility of overmatching may still exist. In our database, we were unable to obtain prehospital information such as bystander CPR, prehospital intubation, and duration of collapse.

Conclusion

Patients monitored with ETCO2 may have a higher possibility of sustained ROSC. However, the overall use of ETCO2 is still low despite strong recommendations in guidelines.

Abbreviations

ACLS: 

Advanced cardiac life support

CCI: 

Charlson comorbidity index

CPR: 

Cardiopulmonary resuscitation

ETCO2

End-tidal carbon dioxide monitoring

ICD-9-CM: 

International Classification of Diseases (Ninth Revision) Clinical Modification

NHI: 

National Health Insurance

OHCA: 

Out-of-hospital cardiac arrest

OR: 

Odds ratio

SES: 

Socioeconomic status

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
School of Medicine, Tzu Chi University
(2)
Emergency Department, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
(3)
Emergency Department, Shin-Kong Wu Ho-Su Memorial Hospital
(4)
Department of Emergency Medicine, Mackay Memorial Hospital
(5)
Department of Public Heath, National Taiwan University

References

  1. Johnson NJ, Salhi RA, Abella BS, Neumar RW, Gaieski DF, Carr BG. Emergency department factors associated with survival after sudden cardiac arrest. Resuscitation. 2013;84:292–7.View ArticlePubMedGoogle Scholar
  2. Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, et al. Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation. 2011;123:e18–209.PubMed CentralView ArticlePubMedGoogle Scholar
  3. Field JM, Hazinski MF, Sayre MR, Chameides L, Schexnayder SM, Hemphill R, et al. Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2010;122:S640–56.View ArticlePubMedGoogle Scholar
  4. Bobrow BJ, Spaite DW, Berg RA, Stolz U, Sanders AB, Kern KB, et al. Chest compression-only CPR by lay rescuers and survival from out-of-hospital cardiac arrest. JAMA. 2010;304:1447–54.View ArticlePubMedGoogle Scholar
  5. Jacobs I, Nadkarni V, Bahr J, Berg RA, Billi JE, Bossaert L, et al. Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Councils of Southern Africa). Circulation. 2004;110:3385–97.View ArticlePubMedGoogle Scholar
  6. Kodali BS, Urman RD. Capnography during cardiopulmonary resuscitation: current evidence and future directions. J Emerg Trauma Shock. 2014;7:332–40.PubMed CentralView ArticlePubMedGoogle Scholar
  7. Shibutani K, Muraoka M, Shirasaki S, Kubal K, Sanchala VT, Gupte P. Do changes in end-tidal PCO2 quantitatively reflect changes in cardiac output? Anesth Analg. 1994;79:829–33.View ArticlePubMedGoogle Scholar
  8. Qvigstad E, Kramer-Johansen J, Tomte O, Skalhegg T, Sorensen O, Sunde K, et al. Clinical pilot study of different hand positions during manual chest compressions monitored with capnography. Resuscitation. 2013;84:1203–7.View ArticlePubMedGoogle Scholar
  9. Einav S, Bromiker R, Weiniger CF, Matot I. Mathematical modeling for prediction of survival from resuscitation based on computerized continuous capnography: proof of concept. Acad Emerg Med. 2011;18:468–75.View ArticlePubMedGoogle Scholar
  10. National Health Insurance Database. http://w3.nhri.org.tw/nhird/en/index.htm. Accessed 11 June 2015.
  11. Lee YK, Lee CC, Chen CC, Wong CH, Su YC. High risk of ‘failure’ among emergency physicians compared with other specialists: a nationwide cohort study. Emerg Med J. 2013;30(8):620–2.PubMed CentralView ArticlePubMedGoogle Scholar
  12. Hou SW, Lee YK, Hsu CY, Lee CC, Su YC. Increased risk of acute pancreatitis in patients with chronic hemodialysis: a 4-year follow-up study. PLoS One. 2013;8:e71801.PubMed CentralView ArticlePubMedGoogle Scholar
  13. Cheng PL, Lin HY, Lee YK, Hsu CY, Lee CC, Su YC. Higher mortality rates among the elderly with mild traumatic brain injury: a nationwide cohort study. Scand J Trauma Resusc Emerg Med. 2014;22:7.PubMed CentralView ArticlePubMedGoogle Scholar
  14. Lee Y-K, Lee C-W, Huang M-Y, Hsu C-Y, Su Y-C. Increased risk of ischemic stroke in patients with mild traumatic brain injury: a nationwide cohort study. Scand J Trauma Resusc Emerg Med. 2014;22:66.PubMed CentralView ArticlePubMedGoogle Scholar
  15. Ng KJ, Lee YK, Huang MY, Hsu CY, Su YC. Risks of venous thromboembolism in patients with liver cirrhosis: a nationwide cohort study in Taiwan. J Thromb Haemost. 2014;13(2):206–13.View ArticleGoogle Scholar
  16. Lee YK, Chen CC, Lin HY, Hsu CY, Su YC. Propofol for sedation can shorten the duration of ED stay in joints reduction. Am J Emerg Med. 2012;30(8):1352–6.View ArticlePubMedGoogle Scholar
  17. Schneeweiss S. Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics. Pharmacoepidemiol Drug Saf. 2006;15:291–303.View ArticlePubMedGoogle Scholar
  18. Edelson DP, Litzinger B, Arora V, Walsh D, Kim S, Lauderdale DS, et al. Improving in-hospital cardiac arrest process and outcomes with performance debriefing. Arch Intern Med. 2008;168:1063–9.View ArticlePubMedGoogle Scholar
  19. Abella BS, Edelson DP, Kim S, Retzer E, Myklebust H, Barry AM, et al. CPR quality improvement during in-hospital cardiac arrest using a real-time audiovisual feedback system. Resuscitation. 2007;73:54–61.View ArticlePubMedGoogle Scholar
  20. Berdowski J, Berg RA, Tijssen JG, Koster RW. Global incidences of out-of-hospital cardiac arrest and survival rates: systematic review of 67 prospective studies. Resuscitation. 2010;81:1479–87.View ArticlePubMedGoogle Scholar
  21. Boyce LW, Vliet Vlieland TP, Bosch J, Wolterbeek R, Volker G, van Exel HJ, et al. High survival rate of 43 % in out-of-hospital cardiac arrest patients in an optimised chain of survival. Neth Heart J. 2015;23:20–5.PubMed CentralView ArticlePubMedGoogle Scholar
  22. Huang C-H, Huei-Ming Ma M, Chen W-J. Out-of-hospital cardiac arrest in Taipei, Taiwan. Acta Cardiol Sinica. 2006;22:53–7.Google Scholar

Copyright

© Chen et al. 2015

Advertisement